Abstract
Determination of whether multidrug nanocarriers can deliver and release loaded drugs at a predefined synergistic ratio to target cancer cells is crucial. Although there are many successful applications for delivery of multiple drugs, most current carriers are unable to achieve coordinated loading and release, leading to a drug release ratio that disagrees with the predefined loading ratio. In this work, a simple dual-drug delivery system with a flexible and controllable drug release ratio was constructed to deliver two anticancer drugs, doxorubicin (DOX) and curcumin (CUR). The drug ratio of DOX and CUR can be easily tuned for an enhanced synergistic effect, and the drugs can be released at predesigned ratios due to synchronous drug activation and nanoparticle collapse. Drug release at predefined ratios for synergistic anticancer therapy was demonstrated via in vitro and in vivo experiments. Therefore, the dual drug delivery system developed here provides a simple and efficient strategy for combination chemotherapy.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Monsuez JJ, Charniot JC, Vignat N, Artigou JY. Int J Cardiology, 2010, 144: 3–15
Xiao Q, Zhu W, Feng W, Lee SS, Leung AW, Shen J, Gao L, Xu C. Front Pharmacol, 2018, 9: 1534
Rawal S, Patel MM. J Control Release, 2019, 301: 76–109
Heinhuis KM, Ros W, Kok M, Steeghs N, Beijnen JH, Schellens JHM. Ann Oncology, 2019, 30: 219–235
Qin SY, Cheng YJ, Lei Q, Zhang AQ, Zhang XZ. Biomaterials, 2018, 171: 178–197
Jia J, Zhu F, Ma X, Cao Z, Cao ZW, Li Y, Li YX, Chen YZ. Nat Rev Drug Discov, 2009, 8: 111–128
Greco F, Vicent MJ. Adv Drug Deliver Rev, 2009, 61: 1203–1213
Lee SM, O’Halloran TV, Nguyen SBT. J Am Chem Soc, 2010, 132: 17130–17138
Houdaihed L, Evans JC, Allen C. Mol Pharm, 2018, 15: 3672–3681
Hu CMJ, Aryal S, Zhang L. Therapeutic Deliver, 2010, 1: 323–334
Spring BQ, Bryan Sears R, Zheng LZ, Mai Z, Watanabe R, Sherwood ME, Schoenfeld DA, Pogue BW, Pereira SP, Villa E, Hasan T. Nat Nanotech, 2016, 11: 378–387
Wang H, Zhao Y, Wu Y, Hu Y, Nan K, Nie G, Chen H. Biomaterials, 2011, 32: 8281–8290
Cui Y, Xu Q, Chow PKH, Wang D, Wang CH. Biomaterials, 2013, 34: 8511–8520
Vicent MJ, Greco F, Nicholson RI, Paul A, Griffiths PC, Duncan R. Angew Chem Int Ed, 2005, 44: 4061–4066
Chen H, Pazicni S, Krett NL, Ahn RW, Penner-Hahn JE, Rosen ST, O’Halloran TV. Angew Chem Int Ed, 2009, 48: 9295–9299
Liao L, Liu J, Dreaden EC, Morton SW, Shopsowitz KE, Hammond PT, Johnson JA. J Am Chem Soc, 2014, 136: 5896–5899
Pathak RK, Dhar S. J Am Chem Soc, 2015, 137: 8324–8327
Zhou F, Wang P, Peng Y, Zhang P, Huang Q, Sun W, He N, Fu T, Zhao Z, Fang X, Tan W. Angew Chem Int Ed, 2019, 58: 11661–11665
Lin S, Xie P, Luo M, Li Q, Li L, Zhang J, Zheng Q, Chen H, Nan K. Nano Res, 2018, 11: 3619–3635
Camacho KM, Kumar S, Menegatti S, Vogus DR, Anselmo AC, Mitragotri S. J Control Release, 2015, 210: 198–207
Sagnou M, Novikov FN, Ivanova ES, Alexiou P, Stroylov VS, Titov IY, Tatarskiy VV, Vagida MS, Pelecanou M, Shtil AA, Chilov GG. Eur J Med Chem, 2020, 198: 112331
Iyer AK, Khaled G, Fang J, Maeda H. Drug Discovery Today, 2006, 11: 812–818
Acknowledgements
This work was supported by the National Natural Science Foundation of China (51873072, 52073101), Guangdong Provincial Pearl River Talents Program (2019QN01Y088), the Science and Technology Program of Guangzhou (202002030268, 201804020060), and Outstanding Scholar Program of Bioland Laboratory (Guangzhou Regenerative Medicine and Health Guangdong Laboratory) (2018GZR110102001).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest The authors declare no conflict of interest.
Supporting Information
Rights and permissions
About this article
Cite this article
Tu, Y., Zheng, R., Yu, F. et al. Dual drug delivery system with flexible and controllable drug ratios for synergistic chemotherapy. Sci. China Chem. 64, 1020–1030 (2021). https://doi.org/10.1007/s11426-020-9964-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11426-020-9964-x